Search research articles
Contact Us
Filters
Showing results (21-30 of 92) with videos related to
Page
of 10
Sort By:
Frontiers in Oncology
|
November 20, 2012
Preclinical evaluation of racotumomab, an anti-idiotype monoclonal antibody to N-glycolyl-containing gangliosides, with or without chemotherapy in a mouse model of non-small cell lung cancer
Valeria I Segatori, Ana M Vazquez, Daniel E Gomez, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
|
April 8, 2016
Comparability of Antibody-Mediated Cell Killing Activity Between a Proposed Biosimilar RTXM83 and the Originator Rituximab
Hector A Cuello, Valeria I Segatori, Marina Alberto, et al.
Anticancer Research
|
September 10, 2014
Insight into the effect of the vasopressin analog desmopressin on lung colonization by mammary carcinoma cells in BALB/c mice
Juan Garona, Marina Pifano, Alejandra M Scursoni, et al.
Cancer Immunology, Immunotherapy : CII
|
April 7, 2007
T cells are crucial for the anti-metastatic effect of anti-epidermal growth factor receptor antibodies
Greta Garrido, Pablo Lorenzano, Belinda Sánchez, et al.
Clinical & Experimental Metastasis
|
May 6, 2016
Addition of vasopressin synthetic analogue [V(4)Q(5)]dDAVP to standard chemotherapy enhances tumour growth inhibition and impairs metastatic spread in aggressive breast tumour models
Juan Garona, Marina Pifano, Maria B Pastrian, et al.
Breast Cancer Research and Treatment
|
October 15, 2013
Reduction of tumor angiogenesis induced by desmopressin in a breast cancer model
Giselle V Ripoll, Juan Garona, Marina Pifano, et al.
Anticancer Research
|
November 28, 2008
Antitumor effects of desmopressin in combination with chemotherapeutic agents in a mouse model of breast cancer
Giselle V Ripoll, Santiago Giron, Martin J Krzymuski, et al.
Cancer Research
|
May 3, 2003
Inhibition of aggressiveness of metastatic mouse mammary carcinoma cells by the beta2-chimaerin GAP domain
Pablo Lorenzano Menna, Guillermo Skilton, Federico Coluccio Leskow, et al.
Medicina
|
May 6, 2009
[Molecular detection of minimal residual disease in melanoma and solid tumors]
Valeria Vázquez, Laura L Otero, Viviana E Laurent, et al.
Nanomedicine (London, England)
|
November 16, 2018
In vitro and in vivo evaluation of desmopressin-loaded poly(D,L-lactic-co-glycolic acid) nanoparticles for its potential use in cancer treatment
Merari T Chevalier, Juan Garona, Natasha T Sobol, et al.
Page
of 10
Search research articles
Search
Showing results (21-30 of 92) with videos related to
Sort By:
Page
of 10
Frontiers in Oncology
|
November 20, 2012
Preclinical evaluation of racotumomab, an anti-idiotype monoclonal antibody to N-glycolyl-containing gangliosides, with or without chemotherapy in a mouse model of non-small cell lung cancer
Valeria I Segatori, Ana M Vazquez, Daniel E Gomez, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
|
April 8, 2016
Comparability of Antibody-Mediated Cell Killing Activity Between a Proposed Biosimilar RTXM83 and the Originator Rituximab
Hector A Cuello, Valeria I Segatori, Marina Alberto, et al.
Anticancer Research
|
September 10, 2014
Insight into the effect of the vasopressin analog desmopressin on lung colonization by mammary carcinoma cells in BALB/c mice
Juan Garona, Marina Pifano, Alejandra M Scursoni, et al.
Cancer Immunology, Immunotherapy : CII
|
April 7, 2007
T cells are crucial for the anti-metastatic effect of anti-epidermal growth factor receptor antibodies
Greta Garrido, Pablo Lorenzano, Belinda Sánchez, et al.
Clinical & Experimental Metastasis
|
May 6, 2016
Addition of vasopressin synthetic analogue [V(4)Q(5)]dDAVP to standard chemotherapy enhances tumour growth inhibition and impairs metastatic spread in aggressive breast tumour models
Juan Garona, Marina Pifano, Maria B Pastrian, et al.
Breast Cancer Research and Treatment
|
October 15, 2013
Reduction of tumor angiogenesis induced by desmopressin in a breast cancer model
Giselle V Ripoll, Juan Garona, Marina Pifano, et al.
Anticancer Research
|
November 28, 2008
Antitumor effects of desmopressin in combination with chemotherapeutic agents in a mouse model of breast cancer
Giselle V Ripoll, Santiago Giron, Martin J Krzymuski, et al.
Cancer Research
|
May 3, 2003
Inhibition of aggressiveness of metastatic mouse mammary carcinoma cells by the beta2-chimaerin GAP domain
Pablo Lorenzano Menna, Guillermo Skilton, Federico Coluccio Leskow, et al.
Medicina
|
May 6, 2009
[Molecular detection of minimal residual disease in melanoma and solid tumors]
Valeria Vázquez, Laura L Otero, Viviana E Laurent, et al.
Nanomedicine (London, England)
|
November 16, 2018
In vitro and in vivo evaluation of desmopressin-loaded poly(D,L-lactic-co-glycolic acid) nanoparticles for its potential use in cancer treatment
Merari T Chevalier, Juan Garona, Natasha T Sobol, et al.
Page
of 10